From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce - PubMed
5 hours ago
- #Cardio-Kidney-Metabolic Diseases
- #Clinical Guidelines
- #Healthcare Implementation
- International guidelines set standards for managing type 2 diabetes (T2D), obesity, cardiovascular disease (CVD), metabolic dysfunction-associated steatotic liver disease (MASLD), and chronic kidney disease (CKD).
- National implementation of these guidelines remains inconsistent, leading to gaps between recommendations and real-world practice.
- Key barriers include linguistic and cultural adaptation, limited clinician communication, and fragmented regulatory and reimbursement processes.
- Strategies to improve implementation include concise translations, digital platforms, decision-support tools, and integration into medical education.
- Structured monitoring and evaluation frameworks with feedback and incentives are essential for effective guideline adoption.
- Coordination among medical societies, governmental authorities, payers, and patient representatives is crucial for equitable and sustainable access to care.
- Evidence shows that systematic, context-sensitive approaches can improve patient outcomes.
- The commentary emphasizes priorities for national implementation to bridge the gap between guideline publication and clinical practice.